What does HERS stand for?

Heart and Estrogen/Progestin Replacement Study

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Human Exposure/Rodent Potency (carcinogenic risk) Half Earnings for Retired Personnel Early Severance (UK) Hanford Emergency Response Planning Guideline Higher Education Relevance and Quality Agency Health Education Risk Reduction Human Estrogen-Related Receptor 1 Human Estrogen Related Receptor-2 Higher Education Regulatory Review Group (UK) Health Research Resource Office Head End Ring Switching (Protocol)		Helicopter Expedient Refueling System High Energy Range Spectrometer Higher Education Resources Services Home Energy Rating System Hydrogeochemical Engineering and Remediation of Soil (Lab; Technical University of Crete) Hyperion Energy Recovery System Hysterectomy Education Resources and Services (Foundation) Highway Economic Requirements - State Version Health Resources and Services Administration Home Energy Rating Systems Council (Washington, DC)

Samples in periodicals archive:

The Heart and Estrogen/progestin Replacement Study (HERS) Research Group (I and later II) studies in women who had known preexisting cardiovascular disease initially raised questions about the increase in heart attacks in the first year of hormone therapy use, but it was the publication of the WHI few years later that raised the alarm.

Menopause and hormone therapy--how confused are you?

1998: Heart and Estrogen/Progestin Replacement Study (HERS) clinical trial says that postmenopausal hormones did not protect women with existing heart disease from subsequent heart attacks.

Questions remain about safety of hormone therapy

Another randomized trial, the Heart and Estrogen/Progestin Replacement Study [HERS] concluded that estrogen combined with progestin has no beneficial effects on the heart in women with a history of heart disease.

What is menopause?

BUSINESS WIRE)--April 29, 2003 In recent months, the results of the Women's Health Initiative (WHI) and the Heart and Estrogen/Progestin Replacement Study (HERS) not only questioned the proposed beneficial effects of hormone replacement therapy (HRT) on cardiovascular health in women, but concluded that HRT may even increase a woman's risk of developing cardiovascular disease.

Protecting Women's Cardiovascular Health after Negative HRT Studies ...

THE HEART AND ESTROGEN/PROGESTIN REPLACEment Study (HERS) hypothesized that postmenopausal hormone use in women with established cardiovascular disease would reduce recurrence of cardiovascular events.

Postmenopausal Hormone Use and Secondary Prevention of Coronary ...

The other study published by JAMA was a follow up to the Heart and Estrogen/Progestin Replacement Study called HERS II.

Many Women Stop Combination Hormone Replacement - HRT - Therapy But ...

The report was precipitated by two recent clinical trials -- the Women's Health Initiative (WHI) and the Heart and Estrogen/progestin Replacement Study (HERS) -- providing new knowledge that has altered the benefit-risk ratio for postmenopausal hormone therapy use, especially in women at risk for coronary heart disease (CHD).

Revised Advisory On Postmenopausal Hormone Therapy; The North ...

The clinical trials -- the Women's Health Initiative (WHI) and the Heart and Estrogen/progestin Replacement Study (HERS) -- provided new knowledge that has altered the benefit-risk ratio for postmenopausal hormone therapy use, especially in women at risk for coronary heart disease (CHD).

ADVANCE/Postmenopausal Hormone Therapy Revisited; the North American ...